by Stephen Grcevich MD | Oct 26, 2017 | ADHD, Controversies
The FDA has again approved a generic version of the most commonly prescribed medication for teens in the U.S. without requiring proof that the new product works as well as what kids are currently taking. The FDA took this action after withdrawing approval of the last...
by Stephen Grcevich MD | Oct 19, 2016 | ADHD, Advocacy, Controversies
Editor’s Notes: The FDA announced plans to rescind the approval of generic versions of Concerta manufactured by Kremers Urban Pharmaceuticals and Mallinckrodt Pharmaceuticals. The drug companies have until mid-November to file a request for a hearing to appeal the...
